| Bioactivity | TT-232 TFA (CAP-232 TFA; TLN-232 TFA) is an analogue of somatostatin. TT-232 TFA can induce apoptosis of pancreatic tumor cell lines, inhibit tyrosine kinase activity and stimulate tyrosine phosphatase activity in colon tumor cell lines. TT-232 TFA inhibits the proliferation of tumor cells, induces apoptosis of tumor cells and shows strong anti-tumor effects. TT-232 TFA can be used in the development of anti-tumor drugs and the study of apoptosis mechanism[1]. |
| CAS | 2703745-48-4 |
| Formula | C47H59F3N10O11S2 |
| Molar Mass | 1061.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li H, et al. Synthesis, conformational analysis and bioactivity of Lan‐7, a lanthionine analog of TT‐232[J]. Journal of Peptide Science: An Official Publication of the European Peptide Society, 2000, 6(1): 26-35. |
TT-232 TFA
CAS: 2703745-48-4 F: C47H59F3N10O11S2 W: 1061.16
TT-232 TFA (CAP-232 TFA; TLN-232 TFA) is an analogue of somatostatin. TT-232 TFA can induce apoptosis of pancreatic tumo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.